$ICCRW
iCoreConnect Inc. Stock $iccrw

$iccrw Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000147793222005934 Filed on August 12, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$1.889M	$2.011M	$2.044M
YoY Change	38.36%	104.93%	190.32%
Cost Of Revenue	$517.7K	$621.3K	$634.2K
YoY Change	22.98%	132.06%	164.23%
Gross Profit	$1.371M	$1.390M	$1.410M
YoY Change	45.21%	94.76%	203.83%
Gross Profit Margin	72.59%	69.11%	68.97%
Selling, General & Admin	$2.152M	$2.262M	$1.950M
YoY Change	60.27%	125.29%	127.75%
% of Gross Profit	156.93%	162.72%	138.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$286.6K	$258.3K	$63.81K
YoY Change	-25.21%	18.27%	9229.53%
% of Gross Profit	20.9%	18.59%	4.53%
Operating Expenses	$2.438M	$2.602M	$2.406M
YoY Change	43.98%	107.39%	116.95%
Operating Profit	-$1.067M	-$1.212M	-$996.6K
YoY Change	42.42%	124.05%	54.48%
Interest Expense	$216.5K	$189.2K	-$155.7K
YoY Change	121.96%	104.46%	-7.22%
% of Operating Profit
Other Income/Expense, Net	-$334.8K	-$275.2K	$89.99K
YoY Change	-6.08%	-73.6%
Pretax Income	-$1.402M	-$1.487M	-$1.542M
YoY Change	26.79%	-6.07%	89.72%
Income Tax
% Of Pretax Income
Net Earnings	-$1.402M	-$1.487M	-$1.542M
YoY Change	26.79%	-6.07%	89.72%
Net Earnings / Revenue	-74.23%	-73.94%	-75.46%
Basic Earnings Per Share
Diluted Earnings Per Share	-$8.132K	-$8.628K	-$9.014K
COMMON SHARES
Basic Shares Outstanding	172.5M shares	172.2M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$162.8K	$164.3K	$810.1K
YoY Change	-76.71%	-80.58%	317.2%
Cash & Equivalents	$162.8K	$164.3K	$810.1K
Short-Term Investments
Other Short-Term Assets	$368.4K	$400.0K	$390.4K
YoY Change	102.48%	202.95%	703.77%
Inventory
Prepaid Expenses
Receivables	$505.1K	$701.9K	$715.7K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.036M	$1.266M	$1.916M
YoY Change	-24.09%	4.47%	356.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$79.93K	$85.73K	$1.170M
YoY Change	57.95%	468.14%	669.01%
Goodwill	$1.485M	$1.485M	$1.485M
YoY Change	-51.69%	15.01%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$5.711M	$5.969M	$6.267M
YoY Change	-5.45%	32.76%	168.7%
TOTAL ASSETS
Total Short-Term Assets	$1.036M	$1.266M	$1.916M
Total Long-Term Assets	$5.711M	$5.969M	$6.267M
Total Assets	$6.747M	$7.235M	$8.184M
YoY Change	-8.89%	26.75%	197.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.004M	$1.680M	$1.243M
YoY Change	61.12%	101.6%	26.18%
Accrued Expenses	$279.5K	$283.7K	$1.046M
YoY Change	377.83%	503.17%	1250.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.045M	$1.604M	$1.776M
YoY Change	237.55%	-32.38%	83.99%
Total Short-Term Liabilities	$6.344M	$3.568M	$4.099M
YoY Change	152.63%	8.64%	100.81%
LONG-TERM LIABILITIES
Long-Term Debt	$1.578M	$3.675M	$3.683M
YoY Change	-42.62%
Other Long-Term Liabilities	$739.5K	$774.3K	$32.32K
YoY Change	1304.29%	940.14%	-75.99%
Total Long-Term Liabilities	$2.317M	$4.450M	$3.716M
YoY Change	-17.31%	5877.4%	2660.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.344M	$3.568M	$4.099M
Total Long-Term Liabilities	$2.317M	$4.450M	$3.716M
Total Liabilities	$8.661M	$8.018M	$7.815M
YoY Change	63.0%	138.71%	259.14%
SHAREHOLDERS EQUITY
Retained Earnings	-$87.23M	-$85.82M	-$84.34M
YoY Change	7.25%	8.71%
Common Stock	$172.4K	$172.5K
YoY Change	8.31%	13.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.914M	-$782.4K	$368.8K
YoY Change
Total Liabilities & Shareholders Equity	$6.747M	$7.235M	$8.184M
YoY Change	-8.89%	26.75%	197.35%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.402M	-$1.487M	-$1.542M
YoY Change	26.79%	-6.07%	89.72%
Depreciation, Depletion And Amortization	$286.6K	$258.3K	$63.81K
YoY Change	-25.21%	18.27%	9229.53%
Cash From Operating Activities	-$240.7K	-$385.6K	-$1.049M
YoY Change	-73.0%	20.04%	46.73%
INVESTING ACTIVITIES
Capital Expenditures	-$71.05K	-$66.60K	-$63.30K
YoY Change	-95.05%	-96.51%	30.03%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$71.05K	-$66.60K	-$63.30K
YoY Change	-95.05%	-96.51%	30.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$350.0K
YoY Change			-75.31%
Debt Paid & Issued, Net			$499.0K
YoY Change
Cash From Financing Activities	310.4K	-193.7K	$1.851M
YoY Change	-85.76%	-106.72%	94.75%
NET CHANGE
Cash From Operating Activities	-240.7K	-385.6K	-$1.049M
Cash From Investing Activities	-71.05K	-66.60K	-$63.30K
Cash From Financing Activities	310.4K	-193.7K	$1.851M
Net Change In Cash	-1.430K	-645.8K	$738.3K
YoY Change	-99.03%	-199.07%	295.74%
FREE CASH FLOW
Cash From Operating Activities	-$240.7K	-$385.6K	-$1.049M
Capital Expenditures	-$71.05K	-$66.60K	-$63.30K
Free Cash Flow	-$169.7K	-$319.0K	-$986.1K
YoY Change	-131.27%	-120.07%	47.95%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Finite Lived Customer Lists Gross FiniteLivedCustomerListsGross	2710127	usd
CY2021Q4	us-gaap	Finite Lived Customer Lists Gross FiniteLivedCustomerListsGross	3069874	usd
CY2022Q2	us-gaap	Deferred Revenue Leases Current DeferredRevenueLeasesCurrent	0	usd
CY2021Q4	us-gaap	Deferred Revenue Leases Current DeferredRevenueLeasesCurrent	20419	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1210095	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1487127	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1583233	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3833541	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	92454	usd
	us-gaap	Interest Paid Net InterestPaidNet	233465	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	1389878	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	713650	usd
	us-gaap	Gross Profit GrossProfit	2799537	usd
	us-gaap	Gross Profit GrossProfit	1177618	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2261577	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1003870	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4293934	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1860258	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	340245	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	250715	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	714100	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	503412	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	2601822	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1254585	usd
	us-gaap	Operating Expenses OperatingExpenses	5008034	usd
	us-gaap	Operating Expenses OperatingExpenses	2363670	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1211944	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-1542235	usd
	dei	Entity Registrant Name EntityRegistrantName	iCoreConnect Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-4182867
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	368753	usd
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	86000	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	172473691	shares
	dei	Entity Address Address Line1 EntityAddressAddressLine1	529 E. Crown Point Road
	icct	Number Of Options Nonvested Forfeited Expired NumberOfOptionsNonvestedForfeitedExpired	0	shares
CY2022Q2	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.001
	icct	Weighted Average Grant Date Fair Value Nonvested Vested WeightedAverageGrantDateFairValueNonvestedVested	0
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	icct	Weighted Average Grant Date Fair Value Nonvested Forfeited Expired WeightedAverageGrantDateFairValueNonvestedForfeitedExpired	0
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	icct	Number Of Warrants Outstanding Granted NumberOfWarrantsOutstandingGranted	0	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	172473691	shares
	icct	Number Of Warrants Outstanding Forfeited Expired NumberOfWarrantsOutstandingForfeitedExpired	0	shares
	icct	Weighted Average Exercise Price Of Warrants Granted WeightedAverageExercisePriceOfWarrantsGranted	0
	icct	Weighted Average Exercise Price Of Warrants Forfeited Expired WeightedAverageExercisePriceOfWarrantsForfeitedExpired	0
	dei	Document Type DocumentType	10-Q
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	167493479	shares
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q2	us-gaap	Revenues Revenues	2011161	usd
CY2021Q2	us-gaap	Revenues Revenues	981378	usd
	us-gaap	Revenues Revenues	4055050	usd
	dei	Entity File Number EntityFileNumber	000-52765
	us-gaap	Revenues Revenues	1685379	usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001408057
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2021Q4	us-gaap	Preferred Stock No Par Value PreferredStockNoParValue	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	172473691	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	167493479	shares
	icct	Number Of Options Warrants Outstanding Exercised NumberOfOptionsWarrantsOutstandingExercised	0	shares
	icct	Number Of Options Warrants Outstanding Forfeited NumberOfOptionsWarrantsOutstandingForfeited	0	shares
	icct	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	0
	icct	Weighted Average Exercise Price Forfeited WeightedAverageExercisePriceForfeited	0
	icct	Number Of Options Nonvested Vested NumberOfOptionsNonvestedVested	0	shares
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 250
	dei	Entity Address City Or Town EntityAddressCityOrTown	Ocoee
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34761
	dei	City Area Code CityAreaCode	888
	dei	Local Phone Number LocalPhoneNumber	810-7706
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	621283	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	300000	usd
CY2022Q1	icct	Stock Compensation Expense StockCompensationExpense	255697	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	267728	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1255513	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	507761	usd
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	703118	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-540935	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2208497	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1186052	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	189183	usd
	us-gaap	Interest Expense InterestExpense	260323	usd
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	86000	usd
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	1281176	usd
	us-gaap	Restructuring Charges RestructuringCharges	386000	usd
	us-gaap	Restructuring Charges RestructuringCharges	1281176	usd
CY2022Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2021Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	331404	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-89993	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	331404	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-275183	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1042298	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-820865	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3029362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2396147	usd
CY2022Q2	icct	Net Loss Per Share Available To Common Stockholders Basic And Diluted NetLossPerShareAvailableToCommonStockholdersBasicAndDiluted	-0.01
CY2021Q2	icct	Net Loss Per Share Available To Common Stockholders Basic And Diluted NetLossPerShareAvailableToCommonStockholdersBasicAndDiluted	-0.01
	icct	Net Loss Per Share Available To Common Stockholders Basic And Diluted NetLossPerShareAvailableToCommonStockholdersBasicAndDiluted	-0.02
	icct	Net Loss Per Share Available To Common Stockholders Basic And Diluted NetLossPerShareAvailableToCommonStockholdersBasicAndDiluted	-0.02
CY2022Q2	icct	Weighted Average Number Of Shares Basic And Diluted WeightedAverageNumberOfSharesBasicAndDiluted	172353044	shares
CY2021Q2	icct	Weighted Average Number Of Shares Basic And Diluted WeightedAverageNumberOfSharesBasicAndDiluted	145126070	shares
	icct	Weighted Average Number Of Shares Basic And Diluted WeightedAverageNumberOfSharesBasicAndDiluted	171723963	shares
	icct	Weighted Average Number Of Shares Basic And Diluted WeightedAverageNumberOfSharesBasicAndDiluted	131287660	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-628940	usd
CY2021Q1	icct	Stock Issued For Cash Amount StockIssuedForCashAmount	1417313	usd
CY2021Q1	icct	Stock Issued For Conversion Of Fees For Services Payable Amount StockIssuedForConversionOfFeesForServicesPayableAmount	481923	usd
CY2021Q1	icct	Stock Compensation Expense Amount StockCompensationExpenseAmount	118796	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-812914	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	576178	usd
CY2021Q2	icct	Stock Issued For Cash Amount StockIssuedForCashAmount	1503500	usd
CY2021Q2	icct	Stock Compensation Expense Amount StockCompensationExpenseAmount	68945	usd
CY2021Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	1283906	usd
CY2021Q2	icct	Stock Issued For Asset Acquisition Of Advantech Amount StockIssuedForAssetAcquisitionOfAdvantechAmount	500000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	250	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1583233	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	2349546	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1005291	usd
CY2022Q1	icct	Stock Issued For Cash Amount StockIssuedForCashAmount	350000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	22387	usd
CY2022Q2	icct	Stock Compensation Expense Amount StockCompensationExpenseAmount	272560	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	45000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-1487127	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-782427	usd
	us-gaap	Profit Loss ProfitLoss	3029362	usd
	us-gaap	Profit Loss ProfitLoss	2396147	usd
	us-gaap	Depreciation Depreciation	10981	usd
	us-gaap	Depreciation Depreciation	1418	usd
	icct	Stock Issued For Conversion Of Accounts Payable StockIssuedForConversionOfAccountsPayable	0	usd
	icct	Stock Issued For Conversion Of Accounts Payable StockIssuedForConversionOfAccountsPayable	7266	usd
	icct	Weighted Average Remaining Years To Vest Nonvested Granted WeightedAverageRemainingYearsToVestNonvestedGranted	P2Y4M24D
	us-gaap	Deferred Sales Inducements Amortization Expense DeferredSalesInducementsAmortizationExpense	469699	usd
	us-gaap	Legal Fees LegalFees	386000	usd
	us-gaap	Legal Fees LegalFees	1281176	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	137676	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
	icct	Gain On Cancellation Of Liabilities GainOnCancellationOfLiabilities	0	usd
	icct	Gain On Cancellation Of Liabilities GainOnCancellationOfLiabilities	331404	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	528257	usd
	us-gaap	Dividends Sharebased Compensation Stock DividendsSharebasedCompensationStock	187741	usd
	icct	Non Cash Interest Expense NonCashInterestExpense	82804	usd
	icct	Non Cash Interest Expense NonCashInterestExpense	26858	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	210502	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	107443	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	87673	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	111916	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	22833	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-17448	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	15946	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11174	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-20419	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-23479	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1434944	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1032119	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	1850022	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4228	usd
	us-gaap	Payments For Software PaymentsForSoftware	129898	usd
	us-gaap	Payments For Software PaymentsForSoftware	108752	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-129898	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1963002	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2420000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1795881	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1112591	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	875887	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	350000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2920813	usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	22500	usd
	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	0	usd
	icct	Conversion Of Accounts Payable Into Common Stock ConversionOfAccountsPayableIntoCommonStock	0	usd
	icct	Conversion Of Accounts Payable Into Common Stock ConversionOfAccountsPayableIntoCommonStock	7266	usd
	icct	Stock Issued For Conversion Of Convertible Debt StockIssuedForConversionOfConvertibleDebt	22387	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1657296	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	838420	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	71807	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7619	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	164261	usd
	us-gaap	Interest Paid Net InterestPaidNet	301644	usd
	icct	Stock Issued For Acquisitions StockIssuedForAcquisitions	0	usd
	icct	Stock Issued For Acquisitions StockIssuedForAcquisitions	500250	usd
	icct	Revenue Description RevenueDescription	The Company’s secondary source of revenue is professional services and other revenue related to customer onboarding, IT services and equipment sales that often precede a subscription service offering purchased by the customer. Approximately 90% of the Company’s revenue is subscription based with the remainder being professional services and other IT related revenue. The geographic concentration of the Company’s revenue is 100% in North America
	icct	Number Of Options Nonvested Ending NumberOfOptionsNonvestedEnding	31180000	shares
	icct	Weighted Average Grant Date Fair Value Nonvested Ending WeightedAverageGrantDateFairValueNonvestedEnding	9.3
	icct	Weighted Average Remaining Years To Vest Nonvested Ending WeightedAverageRemainingYearsToVestNonvestedEnding	P2Y
	us-gaap	Nature Of Operations NatureOfOperations	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>1. NATURE OF OPERATIONS </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">iCoreConnect Inc., (the “Company”), a Nevada Corporation, is a market leading cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise platform of applications and services.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Business Combinations</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During 2021, the Company completed three asset acquisitions which were accounted for as business combinations (i) on April 23, 2021, the Company acquired substantially all the assets of Heyns Unlimited LLC doing business as Advantech (ii) on May 31, 2021, the Company acquired substantially all the assets of BCS Tech Center, Inc.; and (iii) on September 1, 2021, the Company acquired substantially all the assets of Spectrum Technology Solutions, LLC.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Going Concern and Liquidity</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the six months ended June 30, 2022, the Company generated an operating loss of $2,208,497. In addition, at June 30, 2022, the Company has an accumulated deficit, and net working capital deficit of $85,824,625 and $2,301,852 respectively. The Company’s activities were primarily financed through private placements of equity securities and issuance of debt. The Company intends to raise additional capital through the issuance of debt and/or equity securities to fund its operations. The Company is reliant on future fundraising to finance operations in the near future. The financing may not be available on terms satisfactory to the Company, if at all. In light of these matters, there is substantial doubt that the Company will be able to continue as a going concern for a period of 12 months from the issuance date of these financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Currently, management intends to develop a vastly improved healthcare communications system and intends to develop alliances with strategic partners to generate revenues that will sustain the Company. While management believes in the viability of its strategy to increase revenues and in its ability to raise additional funds, there can be no assurances to that effect. Management’s ability to continue as a going concern is ultimately dependent upon its ability to continually increase the Company’s customer base and realize increased revenues from signed contracts. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p>
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2208497	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-85824625	usd
CY2022Q2	icct	Working Capital Deficit WorkingCapitalDeficit	-2301852	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	173700	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	36000	usd
	us-gaap	Advertising Expense AdvertisingExpense	263693	usd
	us-gaap	Advertising Expense AdvertisingExpense	126575	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for derivative instruments in accordance with ASC 815 “Derivatives and Hedging”, which requires additional disclosures about the Company’s objectives and strategies for using derivative instruments, how the derivative instruments and related hedged items are accounted for, and how the derivative instruments and related hedging items affect the financial statements.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. Terms of convertible debt and preferred stock instruments are reviewed to determine whether or not they contain embedded derivative instruments that are required under ASC 815 to be accounted for separately from the host contract and recorded on the balance sheet at fair value. The fair value of derivative liabilities, if any, is required to be revalued at each reporting date, with corresponding changes in fair value recorded in current period operating results.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Freestanding warrants issued by the Company in connection with the issuance or sale of debt and equity instruments are considered to be derivative instruments. Pursuant to ASC 815, an evaluation of specifically identified conditions is made to determine whether the fair value of warrants issued is required to be classified as equity or as a derivative liability.</p>
	icct	Financial Instruments With Down Round Featurespolicytextblock FinancialInstrumentsWithDownRoundFeaturespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company follows the guidance of FASB ASU 2017-11, “Earnings per Share (Topic 260); Distinguishing Liabilities from Equity (Topic 480); and Derivatives and Hedging (Topic 815): (Part I) Accounting for Certain Financial Instruments with Down Round Features. ASU 2017-11 simplifies the accounting for certain financial instruments with down round features, a provision in an equity-linked financial instrument (or embedded feature) that provides a downround adjustment of the current exercise price based on the price of the future equity offerings. The standard requires companies to disregard the down round feature when assessing whether the instrument is indexed to its own stock, for the purposes of determining liability of equity classification. Companies that provide earning per share (“EPS”) data will adjust their diluted EPS calculation for the effect of the feature when triggered (i.e. when the exercise price of the related equity-linked financial instrument is adjusted downward because of the down round feature) and will also recognize the effect of the trigger within equity.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</p>
	icct	Beneficial Conversion Features And Warrantspolicttextblock BeneficialConversionFeaturesAndWarrantspolicttextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company evaluates the conversion feature of convertible debt instruments to determine whether the conversion feature was beneficial as described in ASC 470-30, Debt with Conversion and Other Options. The Company records a beneficial conversion feature (“BCF”) related to the issuance of convertible debt that has conversion features at fixed or adjustable rates that are in-the-money when issued and records the relative fair value of any warrants issued with those instruments. The BCF for the convertible instruments is recognized and measured by allocating a portion of the proceeds to the warrants and as a reduction to the carrying amount of the convertible instrument equal to the intrinsic value of the conversion features, both of which are credited to additional paid-in capital. The Company calculates the fair value of warrants with the convertible instruments using the Black-Scholes valuation model.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Under these guidelines, the Company first allocates the value of the proceeds received from a convertible debt transaction between the convertible debt instrument and any other detachable instruments included in the transaction (such as warrants) on a relative fair value basis. A BCF is then measured as the intrinsic value of the conversion option at the commitment date, representing the difference between the effective conversion price and the Company’s stock price on the commitment date multiplied by the number of shares into which the debt instrument is convertible. The allocated value of the BCF and warrants are recorded as a debt discount and accreted over the expected term of the convertible debt as interest expense. If the intrinsic value of the BCF is greater than the proceeds allocated to the convertible debt instrument, the amount of the discount assigned to the BCF is limited to the amount of the proceeds allocated to the convertible debt instrument.</p>
	icct	Weighted Average Grant Date Fair Value Nonvested Granted WeightedAverageGrantDateFairValueNonvestedGranted	9.2
CY2022Q2	icct	Long Term Debt Gross LongTermDebtGross	5279437	usd
CY2021Q4	icct	Long Term Debt Gross LongTermDebtGross	3863827	usd
CY2022Q2	icct	Less Current Maturities LessCurrentMaturities	-1604018	usd
CY2021Q4	icct	Less Current Maturities LessCurrentMaturities	-2325339	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	3675419	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	1538488	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	4722844	shares
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	350000	usd
	icct	Number Of Options Warrants Outstanding Beginning NumberOfOptionsWarrantsOutstandingBeginning	32275000	shares
	icct	Weighted Average Exercise Price Beginning WeightedAverageExercisePriceBeginning	0.12
	icct	Weighted Average Remaining Contractual Term In Years Beginning WeightedAverageRemainingContractualTermInYearsBeginning	P9Y9M18D
	icct	Aggregate Intrinsic Value Beginning AggregateIntrinsicValueBeginning	0	usd
	icct	Number Of Options Warrants Outstanding Granted NumberOfOptionsWarrantsOutstandingGranted	300000	shares
	icct	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	0.11
	icct	Weighted Average Remaining Contractual Term In Years Granted WeightedAverageRemainingContractualTermInYearsGranted	P9Y6M
	icct	Number Of Options Warrants Outstanding Ending NumberOfOptionsWarrantsOutstandingEnding	32575000	shares
	icct	Weighted Average Exercise Price Ending WeightedAverageExercisePriceEnding	0.12
	icct	Weighted Average Remaining Contractual Term In Years Ending WeightedAverageRemainingContractualTermInYearsEnding	P9Y2M12D
	icct	Aggregate Intrinsic Value Ending AggregateIntrinsicValueEnding	0	usd
	icct	Number Of Options Outstanding Exercisable Ending NumberOfOptionsOutstandingExercisableEnding	1395000	shares
	icct	Weighted Average Exercise Price Exercisable WeightedAverageExercisePriceExercisable	0.24
	icct	Weighted Average Remaining Contractual Term In Years Exercisable Ending WeightedAverageRemainingContractualTermInYearsExercisableEnding	P5Y9M18D
	icct	Aggregate Intrinsic Value Exercisable AggregateIntrinsicValueExercisable	0	usd
	icct	Number Of Options Nonvested Beginning NumberOfOptionsNonvestedBeginning	30880000	shares
	icct	Weighted Average Grant Date Fair Value Nonvested Beginning WeightedAverageGrantDateFairValueNonvestedBeginning	9.9
	icct	Weighted Average Remaining Years To Vest Nonvested Begining WeightedAverageRemainingYearsToVestNonvestedBegining	P2Y3M18D
	icct	Number Of Options Nonvested Granted NumberOfOptionsNonvestedGranted	300000	shares
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	icct	Accumulated Amortization Of Intangible Assets AccumulatedAmortizationOfIntangibleAssets	-4727796	usd
CY2022Q2	icct	Intangible Assets Net IntangibleAssetsNet	3367401	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	703118	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	469669	usd
CY2022Q2	icct	Shares Issued Warrants SharesIssuedWarrants	10600000	shares
	icct	Number Of Warrants Outstanding Beginning NumberOfWarrantsOutstandingBeginning	10600000	shares
	icct	Weighted Average Exercise Price Of Warrants Beginning WeightedAverageExercisePriceOfWarrantsBeginning	0.23
	icct	Weighted Average Remaining Life Of Warrants In Years Beggining WeightedAverageRemainingLifeOfWarrantsInYearsBeggining	P4Y4M24D
	icct	Aggregate Intrinsic Value Of Warrants Beggining AggregateIntrinsicValueOfWarrantsBeggining	715223	usd
	icct	Number Of Warrants Outstanding Ending NumberOfWarrantsOutstandingEnding	10600000	shares
	icct	Weighted Average Exercise Price Of Warrants Ending WeightedAverageExercisePriceOfWarrantsEnding	0.23
	icct	Weighted Average Remaining Life Of Warrants In Years Ending WeightedAverageRemainingLifeOfWarrantsInYearsEnding	P3Y9M18D
	icct	Aggregate Intrinsic Value Of Warrants Ending AggregateIntrinsicValueOfWarrantsEnding	715223	usd
CY2021Q4	us-gaap	Goodwill Goodwill	1484966	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022Q2	us-gaap	Goodwill Goodwill	1484966	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7965297	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021	icct	Accumulated Amortization Of Intangible Assets AccumulatedAmortizationOfIntangibleAssets	-4024677	usd
CY2021Q4	icct	Intangible Assets Net IntangibleAssetsNet	3940621	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8095197	usd
	icct	Summary Of Lease Commitmentstabletextblock SummaryOfLeaseCommitmentstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td colspan="15" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Lease Commitments</strong></p></td></tr><tr style="height:15px"><td colspan="15" style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>as of 06/30/2022</strong></p></td></tr><tr style="height:15px"><td colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Less than 1 year</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>1-3 years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>3-5 years</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td style="width:9%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">283,731</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">748,100</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">417,787</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,449,618</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	us-gaap	Other Commitment OtherCommitment	1449618	usd
CY2021Q3	icct	Obliged Liabilities ObligedLiabilities	863274	usd
	icct	Credit Card Obligations CreditCardObligations	28577	usd
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	350000	usd

Files In Submission

Name	View Source	Status
0001477932-22-005934-index-headers.html	Edgar Link	pending
0001477932-22-005934-index.html	Edgar Link	pending
0001477932-22-005934.txt	Edgar Link	pending
0001477932-22-005934-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
icct-20220630.xsd	Edgar Link	pending
icct_104.htm	Edgar Link	pending
icct_105.htm	Edgar Link	pending
icct_106.htm	Edgar Link	pending
icct_10q.htm	Edgar Link	pending
icct_311.htm	Edgar Link	pending
icct_312.htm	Edgar Link	pending
icct_321.htm	Edgar Link	pending
icct_322.htm	Edgar Link	pending
icct_ex107.htm	Edgar Link	pending
icct_ex108.htm	Edgar Link	pending
icct_ex109.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
icct-20220630_cal.xml	Edgar Link	unprocessable
icct-20220630_lab.xml	Edgar Link	unprocessable
icct-20220630_pre.xml	Edgar Link	unprocessable
icct-20220630_def.xml	Edgar Link	unprocessable
icct_10q_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICCRW
iCoreConnect Inc. Stock $iccrw

2022 Q3 Form 10-Q Financial Statement

#000147793222005934 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCRW iCoreConnect Inc. Stock $iccrw

2022 Q3 Form 10-Q Financial Statement

#000147793222005934 Filed on August 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICCRW
iCoreConnect Inc. Stock $iccrw